Its buying/averaging down time not selling time.
So much on the Horizon.
VascuCel approval.(weeks)
Hpv trial kicking off
Next 4C significant increased revenue.
HSV data released September 2016.(Global eyes watching.)
CardioCel trials.
Stemcell update.
Partnership deals
B2B agreements.
New leaders taking ownership
I could keep going on,missed many.
To keep it real,we need capital.If this comes in a non dilutive form the much needed volume will return to push this up and beyond.
I Hold tight
Reasons to keep holding Admedus shares, page-6
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.05 |
Change
0.000(0.00%) |
Mkt cap ! $327.7M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 191 | $17.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.80 | 10 | 2 |
View Market Depth
| Last trade - 16.16pm 22/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |
Day chart unavailable